230 related articles for article (PubMed ID: 15172967)
1. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene.
Hakobyan N; Kazarian T; Jabbar AA; Jabbar KJ; Valentino LA
Blood; 2004 Oct; 104(7):2060-4. PubMed ID: 15172967
[TBL] [Abstract][Full Text] [Related]
2. c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide.
Wen FQ; Jabbar AA; Chen YX; Kazarian T; Patel DA; Valentino LA
Blood; 2002 Aug; 100(3):912-6. PubMed ID: 12130502
[TBL] [Abstract][Full Text] [Related]
3. Future aspects of hemophilia research and care.
Valentino LA; Scheiflinger F
Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():32-8. PubMed ID: 16804834
[TBL] [Abstract][Full Text] [Related]
4. The F8(-/-) rat as a model of hemophilic arthropathy.
Sørensen KR; Roepstorff K; Wiinberg B; Hansen AK; Tranholm M; Nielsen LN; Kjelgaard-Hansen M
J Thromb Haemost; 2016 Jun; 14(6):1216-25. PubMed ID: 27060449
[TBL] [Abstract][Full Text] [Related]
5. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
Manon-Jensen T; Karsdal MA; Nielsen LN; Kjelgaard-Hansen M; Vandahl B; Olsen EH; Enoksson M; Roepstorff K
J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
[TBL] [Abstract][Full Text] [Related]
6. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency.
Valentino LA; Hakobyan N; Kazarian T; Jabbar KJ; Jabbar AA
Haemophilia; 2004 May; 10(3):280-7. PubMed ID: 15086328
[TBL] [Abstract][Full Text] [Related]
7. EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.
Magisetty J; Pendurthi UR; Esmon CT; Rao LVM
Blood; 2020 Jun; 135(25):2211-2223. PubMed ID: 32294155
[TBL] [Abstract][Full Text] [Related]
8. Blood-induced joint disease: the confluence of dysregulated oncogenes, inflammatory signals, and angiogenic cues.
Valentino LA; Hakobyan N; Enockson C
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S50-7. PubMed ID: 18544426
[TBL] [Abstract][Full Text] [Related]
9. Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.
Sun J; Hakobyan N; Valentino LA; Feldman BL; Samulski RJ; Monahan PE
Blood; 2008 Dec; 112(12):4532-41. PubMed ID: 18716130
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis.
Rodríguez-Merchán EC
Clin Orthop Relat Res; 1997 Oct; (343):6-11. PubMed ID: 9345198
[TBL] [Abstract][Full Text] [Related]
11. [Pathology of synovitis and hemophilic arthropathy].
Roosendaal G; van den Berg HM; Lafeber FP; Bijlsma J
Orthopade; 1999 Apr; 28(4):323-8. PubMed ID: 10335526
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of hemophilic arthropathy and potential targets for therapy.
Pulles AE; Mastbergen SC; Schutgens RE; Lafeber FP; van Vulpen LF
Pharmacol Res; 2017 Jan; 115():192-199. PubMed ID: 27890816
[TBL] [Abstract][Full Text] [Related]
13. A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo.
van Vulpen LFD; Popov-Celeketic J; van Meegeren MER; Coeleveld K; van Laar JM; Hack CE; Schutgens REG; Mastbergen SC; Lafeber FPJG
J Thromb Haemost; 2017 Sep; 15(9):1788-1798. PubMed ID: 28696534
[TBL] [Abstract][Full Text] [Related]
14. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.
Haxaire C; Hakobyan N; Pannellini T; Carballo C; McIlwain D; Mak TW; Rodeo S; Acharya S; Li D; Szymonifka J; Song X; Monette S; Srivastava A; Salmon JE; Blobel CP
Blood; 2018 Sep; 132(10):1064-1074. PubMed ID: 29776906
[TBL] [Abstract][Full Text] [Related]
15. Orthopaedic problems about the ankle in hemophilia.
Rodriguez-Merchan EC
J Foot Ankle Surg; 2012; 51(6):772-6. PubMed ID: 22785085
[TBL] [Abstract][Full Text] [Related]
16. Hemophilic arthropathy.
Luck JV; Silva M; Rodriguez-Merchan EC; Ghalambor N; Zahiri CA; Finn RS
J Am Acad Orthop Surg; 2004; 12(4):234-45. PubMed ID: 15473675
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of hemophilic arthropathy.
Hoots WK
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S18-22. PubMed ID: 16427379
[TBL] [Abstract][Full Text] [Related]
18. A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy.
Zhang F; Xu M; Yang Q; Hua B; Xia B; Lin Z; Xiao X; Monahan PE; Sun J
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31892201
[TBL] [Abstract][Full Text] [Related]
19. Hemophilic arthropathy: Current knowledge and future perspectives.
Gualtierotti R; Solimeno LP; Peyvandi F
J Thromb Haemost; 2021 Sep; 19(9):2112-2121. PubMed ID: 34197690
[TBL] [Abstract][Full Text] [Related]
20. [Conservative management of hemophilic arthropathy].
Müller S; Kurth AA; Hovy L
Orthopade; 1999 Apr; 28(4):347-55. PubMed ID: 10335529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
